この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2016/4/41 分で読めます
Food and Drug Administration Review and Action on Over-the-Counter Time and Extent Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA or Agency) is proposing to amend its nonprescription (over-the-counter or OTC) drug regulations. The proposed rule, if finalized as proposed, would supplement the time and extent application (TEA) process for OTC drugs by establishing timelines and performance metrics for FDA's review of non-sunscreen TEAs, as required by the Sunscreen Innovation Act (SIA). We are also proposing other changes to make the TEA process more efficient.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →